NCT06508021 A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06089616 A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP) Status RECRUITING Phase N/A
NCT05394116 A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05039515 A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). Status TERMINATED Phase PHASE2
NCT04829773 Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT04818398 Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects Status COMPLETED Phase PHASE1
NCT04665323 An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families. Status COMPLETED Phase N/A
NCT03312634 An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva. Status COMPLETED Phase PHASE3
NCT03188666 A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva Status COMPLETED Phase PHASE2
NCT02521792 In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects Status TERMINATED Phase PHASE2
NCT02322255 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP) Status COMPLETED Phase N/A
NCT02279095 An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP) Status COMPLETED Phase PHASE2
NCT02190747 An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects Status COMPLETED Phase PHASE2